BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3944748)

  • 21. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining disease activity in inflammatory bowel disease.
    Cooke WT; Prior P
    J Clin Gastroenterol; 1984 Feb; 6(1):17-25. PubMed ID: 6699391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative usefulness of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of ulcerative colitis].
    Ha JS; Lee JS; Kim HJ; Moon TG; Chang DK; Lee JH; Kim YH; Rhee PL; Kim JJ; Rhee JC
    Korean J Gastroenterol; 2006 Nov; 48(5):313-20. PubMed ID: 17132919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C; Descos L; André F; Vignal J; Druguet M
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract]   [Full Text] [Related]  

  • 25. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease.
    Rodgers AD; Cummins AG
    Dig Dis Sci; 2007 Sep; 52(9):2063-8. PubMed ID: 17436102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute-phase proteins and beta 2 microglobulin in the follow-up of Crohn disease and ulcerative colitis].
    Bollbach R; Rotthauwe HW
    Klin Padiatr; 1985; 197(2):106-10. PubMed ID: 3887012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease.
    Chambers RE; Stross P; Barry RE; Whicher JT
    Eur J Clin Invest; 1987 Oct; 17(5):460-7. PubMed ID: 3121351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing acute phase responses in Crohn's disease and ulcerative colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
    Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].
    Fedak D; Pawlica D; Ciećko-Michalska I; Solnica B; Mach T
    Przegl Lek; 2010; 67(2):114-8. PubMed ID: 20557011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease.
    Sachar DB; Smith H; Chan S; Cohen LB; Lichtiger S; Messer J
    J Clin Gastroenterol; 1986 Dec; 8(6):647-50. PubMed ID: 3805662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute phase proteins in chronic inflammatory bowel disease in childhood.
    Campbell CA; Walker-Smith JA; Hindocha P; Adinolfi M
    J Pediatr Gastroenterol Nutr; 1982; 1(2):193-200. PubMed ID: 6985260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis and Hierarchical Clustering of Blood Results Before Diagnosis in Pediatric Inflammatory Bowel Disease.
    Ashton JJ; Borca F; Mossotto E; Phan HTT; Ennis S; Beattie RM
    Inflamm Bowel Dis; 2020 Feb; 26(3):469-475. PubMed ID: 30561629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.
    Osada T; Ohkusa T; Okayasu I; Yoshida T; Hirai S; Beppu K; Shibuya T; Sakamoto N; Kobayashi O; Nagahara A; Terai T; Watanabe S
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S262-7. PubMed ID: 19120909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
    Andre C; Descos L; Landais P; Fermanian J
    Gut; 1981 Jul; 22(7):571-4. PubMed ID: 6973509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.